祈求
发表于 2025-3-21 16:18:00
书目名称Middle-Income Trap影响因子(影响力)<br> http://figure.impactfactor.cn/if/?ISSN=BK0633645<br><br> <br><br>书目名称Middle-Income Trap影响因子(影响力)学科排名<br> http://figure.impactfactor.cn/ifr/?ISSN=BK0633645<br><br> <br><br>书目名称Middle-Income Trap网络公开度<br> http://figure.impactfactor.cn/at/?ISSN=BK0633645<br><br> <br><br>书目名称Middle-Income Trap网络公开度学科排名<br> http://figure.impactfactor.cn/atr/?ISSN=BK0633645<br><br> <br><br>书目名称Middle-Income Trap被引频次<br> http://figure.impactfactor.cn/tc/?ISSN=BK0633645<br><br> <br><br>书目名称Middle-Income Trap被引频次学科排名<br> http://figure.impactfactor.cn/tcr/?ISSN=BK0633645<br><br> <br><br>书目名称Middle-Income Trap年度引用<br> http://figure.impactfactor.cn/ii/?ISSN=BK0633645<br><br> <br><br>书目名称Middle-Income Trap年度引用学科排名<br> http://figure.impactfactor.cn/iir/?ISSN=BK0633645<br><br> <br><br>书目名称Middle-Income Trap读者反馈<br> http://figure.impactfactor.cn/5y/?ISSN=BK0633645<br><br> <br><br>书目名称Middle-Income Trap读者反馈学科排名<br> http://figure.impactfactor.cn/5yr/?ISSN=BK0633645<br><br> <br><br>
深渊
发表于 2025-3-21 21:15:38
http://reply.papertrans.cn/64/6337/633645/633645_2.png
执
发表于 2025-3-22 03:32:46
http://image.papertrans.cn/m/image/633645.jpg
VERT
发表于 2025-3-22 04:34:08
https://doi.org/10.1007/978-981-15-7401-6middle-income trap; economic transformations; social governance; development issues; Fairness and Justic
prodrome
发表于 2025-3-22 09:42:10
http://reply.papertrans.cn/64/6337/633645/633645_5.png
Glucose
发表于 2025-3-22 15:46:22
Book 2020. China has experienced high-speed economic growth for nearly 40 years since the adoption of the Reform and Opening policies. However, China’s economic growth has been slowing down significantly in recent years. Has China tumbled into the middle-income trap? This book reveals the essence of the midd
一个姐姐
发表于 2025-3-22 18:36:37
http://reply.papertrans.cn/64/6337/633645/633645_7.png
diskitis
发表于 2025-3-23 00:39:53
http://reply.papertrans.cn/64/6337/633645/633645_8.png
Infusion
发表于 2025-3-23 02:13:57
Liposomes: The Science and the Regulatory Landscapel be discussed, followed by a short overview of pharmacological aspects (e.g., pharmacokinetics/disposition, dosing, hypersensitivity). The regulatory landscape as it developed over the years is described next, followed by reflections on the future of this family of lipid, vesicular drug carrier systems.
法律的瑕疵
发表于 2025-3-23 08:41:41
http://reply.papertrans.cn/64/6337/633645/633645_10.png